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ABSTRACT
Despite the potential for patient-reported outcome measures
(PROMs) and experience measures (PREMs) to enhance under-
standing of patient experiences and outcomes they have not, to
date, been widely incorporated into renal registry datasets. This
report summarizes the main points learned from an ERA-EDTA
QUEST-funded consensus meeting on how to routinely collect
PROMs and PREMs in renal registries in Europe. In preparation
for the meeting, we surveyed all European renal registries to es-
tablish current or planned efforts to collect PROMs/PREMs. A
systematic review of the literature was performed. Publications
reporting barriers and/or facilitators to PROMs/PREMs collec-
tion by registries were identiﬁed and a narrative synthesis under-
taken. A group of renal registry representatives, PROMs/PREMs
experts and patient representatives then met to (i) share any ex-
perience renal registries in Europe have in this area; (ii) establish
how patient-reported data might be collected by understanding
how registries currently collect routine data and how patient-re-
ported data is collected in other settings; (iii) harmonize the fu-
ture collection of patient-reported data by renal registries in© The Author 2015. Published by Oxford University Press on behalf of ERA-
EDTA. This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and
reproduction in any medium, provided the original work is properly cited. For
commercial re-use, please contact journals.permissions@oup.com
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Europe by agreeing upon preferred instruments and (iv) to iden-
tify the barriers to routine collection of patient-reported data in
renal registries in Europe. In total, 23 of the 45 European renal
registries responded to the survey. Two reported experience in
collecting PROMs and three stated that they were actively explor-
ing ways to do so. The systematic review identiﬁed 157 potential-
ly relevant articles of which 9 met the inclusion criteria and were
analysed for barriers and facilitators to routine PROM/PREM
collection. Thirteen themes were identiﬁed and mapped to a
three-stage framework around establishing the need, setting up
and maintaining the routine collection of PROMs/PREMs. At
the consensus meeting some PROMs instruments were agreed
for routine renal registry collection (the generic SF-12, the dis-
ease-speciﬁc KDQOL™-36 and EQ-5D-5L to be able to derive
quality-adjusted life years), but furtherworkwas felt to be needed
before recommending PREMs. Routinely collecting PROMs and
PREMs in renal registries is important if we are to better under-
stand what matters to patients but it is likely to be challenging;
close international collaboration will be beneﬁcial.
Keywords: patient-reported measures, quality indicators,
registry
INTRODUCTION
Established renal failure is a chronic disease with signiﬁcant as-
sociatedmorbidity. Although it affects a small proportion of the
general population (0.06–0.12% in countries across Europe in
2012) (Table A.4.3 in [1]), the quality of life of those affected
is markedly lower than for those with most other chronic con-
ditions and cancers [2]. Standard dialysis provides the equiva-
lent of only 10% of kidney function so many patients are
chronically tired, depressed and suffer pain; and many of
these symptoms go unrecognized [3].
The success of treatments for renal failure has been historic-
ally assessed using measures considered important by doctors,
such as phosphate level or urea clearance. Although instru-
ments measuring the patient’s perspective have been available
for decades, their incorporation into routine clinical practice
has until recently been slow. A number of patient-reported
measures exist:
• Patient-reported outcome measures (PROMs) include any
metric assessing health, illness or health care beneﬁts from
the patient’s perspective; in general they take the form of a
questionnaire and more speciﬁcally a quality of life or symp-
tom questionnaire. In routine clinical practice, PROMs have
the potential to highlight relevant symptoms and changes in
symptoms, promote patient engagement in their treatment
[4] and improve patient outcomes [5]. Summarizing PROM
results across individual patients, for example at the level of
treatments or hospitals, they could be used to inform a pa-
tient’s choice of treatment or assess quality of care across
different hospitals [6, 7]. The importance of PROMs as end
points in clinical trials is also increasingly being recognized [8].
• Patient-reported experience measures (PREMs) capture in-
formation about the healthcare experience as perceived by
the patient. They can refer to a variety of issues, ranging
from cleanliness of facilities to information provision, and
from timeliness of transport to family members0 access to
health professionals [9]. In routine clinical practice, PREMs
can be used to improve quality in clinical services [10].
• Measures reﬂecting aspects of patient involvement in their
health care, including patient activation [11] and informed
and shared decision-making [12].
Dialysis and transplantation are in the almost unique pos-
ition of having an existing infrastructure of regional, national
and international registries for collecting and reporting infor-
mation on all patients receiving treatment. Quality of care, as
measured against nationally and internationally agreed stan-
dards, can be publicly reported and compared between centres
and between countries. These instruments were usually devel-
oped formeasurement at the patient level, however, and caution
will need to be exercised when comparing differences between
centres or countries until more is known about their perform-
ance at these levels. To be able to report symptom burden and
quality of life-adjusted survival alongside laboratory measures
such as haemoglobin, calcium, phosphate and dialysis dose
would be a major step forward in reporting what is important
to patients. While some components of quality of life have been
shown to be modiﬁable (e.g. the physical component summary
score of the SF-36 in the Frequent Haemodialysis Network
Short Daily Trial [13]), others reﬂect the broader social con-
struct in which the patient functions which so could prove to
be beyond the inﬂuence of the health care provider.
Part of this infrastructure is the ERA-EDTA Registry, which
collects data on renal replacement therapy (RRT) via the national
and regional renal registries in Europe: individual patient data is
available from 31 national and regional registries in 17 countries
and aggregated data from a further 14 national registries [1]. The
data items collected vary by country but can include demograph-
ics, primary renal disease, RRT treatment history, date and cause
of death, comorbidities, details of physical examination (e.g.
weight, blood pressure), laboratory measurements (e.g. haemo-
globin, albumin) and details of certain therapies given. At pre-
sent, none of the national and regional registries report
patient-reported outcome/experience measures to the ERA-
EDTA Registry, but it is not certain what data are collected
locally. This paper reports the results of a survey to capture exist-
ing experiences of European renal registries in PROMandPREM
collection and a literature review of the facilitators and barriers to
registries routinely collecting PROMs and PREMs. It then
presents the discussions and conclusions of an international con-
sensus meeting, funded by the QUEST initiative of the
ERA-EDTA, aimed at promoting and harmonizing the routine
collection of patient-reported data by European renal registries.
SURVEY OF EUROPEAN RENAL REGISTRIES
Prior to the consensus meeting, the organizers contacted all 45
European renal registries (using the ERA-EDTA Registry email
contact list) asking for responses to the following questions:
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(i) Does your registry currently collect any quality of life or
patient satisfaction/experience measures?
(ii) If so, what measures do you use and how are these data
collected?
(iii) If not, have you tried to collect these measures in the past
and/or do you have plans to collect these measures in the
future?
The survey did not ask about patient involvement question-
naires, patient activation or shared decision making, as these
had not been included in the original application for funding.
Responses were received from 23 out of 45 registries. Only two
registries (Austria and France) reported experience in the collec-
tion of PROMs/PREMs and a further three registries reported
that they were actively exploring this possibility (Norway,
Romania and Sweden). From these responses, there was no
obvious consensus on the instruments or methods to use in
the collection of PROMs and PREMs, although some barriers
to the process were identiﬁed. These included low response
rates, legal constraints and the burden on staff and patients.
LITERATURE REVIEW AND NARRATIVE
SYNTHESIS
A systematic review of the literature was conducted with the
primary aim of identifying facilitators and barriers to the rou-
tine collection of patient-reported measures by chronic disease
registries. Medline and EMBASE databases were searched from
1981 to 2013 to identify papers reporting on the routine collec-
tion of patient-reported outcome, experience or quality of life
data by chronic disease registries, including both renal and
non-renal registries. Full details of the search terms are avail-
able in the Supplementary data. Abstracts of papers identiﬁed
in the search were reviewed and full text versions obtained
of those which appeared potentially relevant. Two reviewers
(K.B. and F.C.) independently screened the full-text papers
for relevancy, and—from the relevant papers—systematically
identiﬁed any recurring themes across studies.
The search yielded 762 hits, of which 157 papers were deemed
to be potentially relevant at the title and abstract screening stage
based on pre-deﬁned criteria; 9 papers were ﬁnally selected
[14–22] and included in the narrative synthesis conducted
according to guidelines provided by Popay et al. [23].
All nine of the selected papers were read by two independent
researchers (K.B. and F.C.) and the two most relevant papers
used to conduct a preliminary synthesis [20, 21]. Relationships
between the data were then explored using all nine studies to
develop a broad conceptual model in order to provide an appro-
priate framework for further exploration of relationships in the
data (Figure 1). This framework comprised three stages: estab-
lishing the need for, setting-up and maintaining routine
PROM/PREM data collection. In total, 13 themes were identi-
ﬁed and agreed by two independent researchers (K.B. and F.C.)
across the three stages of the conceptual model, each compris-
ing a number of subthemes (Table 1). For each theme that re-
sulted from the thematic analysis, we identiﬁed facilitators and
barriers to implementation as reported in the selected papers,
which we then translated into a series of recommendations
(listed in Table 1).
Establishing the need for PROM/PREM data in registries
was largely broken down into two main themes: recogniz-
ing the importance of PROMs and agreeing that, with all
the other data they collect, registries provide a good back-
drop for the collection of patient-reported data.
Several of the themes and subthemes were identiﬁed as
important in setting up PROM/PREM collection by regis-
tries. Methodological issues associated with PROMs were
identiﬁed, and recommendations developed based on the
need for PROMs expertise, national and international
support, stakeholder involvement (including patient and
public involvement) and international standardization.
As well as these themes, some speciﬁc issues relating to
resources and practical aspects were identiﬁed.
More exclusive tomaintaining a PROM/PREMprogramme
were themes related to ensuring useful, high-impact output
and the process of maintaining trust in the data. Several
themes crossed the ‘set-up’ and ‘maintenance’ parts of the
model, including subthemes under design and evaluation,
and technological/information governance.
F IGURE 1 : Framework for narrative synthesis.
N
D
T
P
E
R
S
P
E
C
T
IV
E
S
R e p o r t i n g P R O M s a n d P R E M s t o r e g i s t r i e s 3
 at U
niversity of Leeds on M
ay 18, 2015
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
Table 1. Summary of subthemes identiﬁed by the narrative synthesis process, organized by theme
Establishing need (1) Recognition of the importance of PROMs across all stakeholders:
• Highlight the potential clinical outcomes of PROMs
• Target evidence at all stakeholders
• Highlight recommendations from national/international organizations
• Identify research supporting the need for PROMs
• Capitalize on the increasing recognition of PROMs in other diseases
• Utilize the power of patient organizations to lobby policy makers
(2) Agreement that registries are a good way to collect PROMs:
• Registry-based collection may overcome some of the methodological limitations (e.g. larger samples, multiple time points,
ability to account for interactions)
• Registries can be used as a sampling frame to target speciﬁc subgroups
• Provide evidence that registries are a cost-effective way to collect these data
• Highlight ability to describe equity of access to treatment/quality assurance
• Highlight ability to describe characteristics of responders/non-responders
Set up (3) PROM methodological issues
• Recognize methodological issues and how these will affect design and interpretation
• Recognize the importance of using properly translated and validated instruments for a population
• Consider undertaking a feasibility study when selecting the instruments
• Consider where the control data for measures came from
(4) PROM methodological expertise
• Involve experts at all stages of project design and development
• Provide staff with training in collecting, analysing and interpreting PROMs data
(5) National and international support
• Mandate or incentivise the collection of PROM data
• Obtain ﬁnancial support from respected national and international organizations
• Coordinate expertise and infrastructure at a national level
• Understand laws and permissions in different countries with respect to PROMs
(6) Patient and public involvement
• Generate interest among the public and patients
• Involve patients in objective setting and the design of data collection and reporting
• Involve an international umbrella organization of patient associations where possible
(7) International standardization
• Agree on internationally standardized systems, deﬁnitions, data architecture and timings for data collection
• Aim for an internationally agreed core data set to enable international data pooling
• Design a system that can be easily adopted by subsequent countries wanting to join
(8) Stakeholder involvement in objective setting
• Involve all stakeholders in objective setting and design
• Aim to reach consensus of key objectives at/before the design stage
• Deﬁne relationships and responsibilities at the beginning
• Avoid having too many stakeholders
(9) Practical considerations including resources
• Obtain sufﬁcient funding for staff, equipment etc
• Minimize the burden of administration at the clinic level
• Provide clear guidelines and training for staff administering PROMs
• Work out the most cost-effective way of collecting PROMs
• Consider using a PROM registry that is not disease speciﬁc so resources can be shared
• Set realistic timescales
(10) Design and ongoing evaluation/modiﬁcation
• Understand current data collection status of existing registries
• Offer a range of modes of completion for questionnaires, including paper and electronic.
• Align the data collection to objectives set by stakeholders
• Ensure design has capacity for ﬂexibility as the project develops
• Set criteria for evaluation of project in advance
• Aim to minimize the burden to patients
• Consider dividing up the project into a number of work packages, each with its own lead
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A number of these themes, such as the need for stakeholder
involvement, PROMs expertise and international standardiza-
tion, were used when planning the consensus meeting. The re-
sults of the review were also presented to the delegates during
the preparatory session of the consensus meeting.
CONSENSUS MEETING
In June 2014, experts from across Europe participated in a con-
sensus meeting in Bristol, UK. Invited to the meeting were par-
ticipants representing all European renal registries with an
interest in collecting PROMs and PREMs routinely; experts
on PROMs, PREMs and shared decision making; a representa-
tive from the National Cancer Registry Ireland with experience
in routine PROMs collection among cancer patients, and;
patient and carer representatives from a large UK kidney patient
charity the National Kidney Federation. The objectives of this
meeting were to (i) share any experience renal registries in Eur-
ope already have in this area; (ii) establish how patient-reported
data might be collected by understanding how registries cur-
rently collect routine data and how patient-reported data is col-
lected in other settings; (iii) harmonize the future collection of
patient-reported data by renal registries in Europe by agreeing
upon preferred instruments and (iv) identify the barriers to
routine collection of patient-reported data in renal registries
in Europe.
The opening sessions of the meeting comprised the presen-
tation of the results of the narrative synthesis followed by a
series of presentations aimed at addressing the ﬁrst two objec-
tives. Representatives from four of the ﬁve renal registries with
PROMs/PREMs experience (France [24], Norway, Romania
and Sweden) and the National Cancer Registry Ireland shared
their experience of PROMs/PREMs data collection. The direct-
or of the ERA-EDTA Registry then described the current state
of routine data collection in renal registries in Europe; this was
followed by presentations from three experts in PROMs,
PREMs and shared decision making. Summaries of the three
methodological presentations follow.
EXPERT REPORTS
Patient-reported outcome measures—Elizabeth Gibbons,
patient-reported outcome measurement group,
University of Oxford, UK
PROMs capture patients’ perceptions of their health and
quality of life, and vary according to factors such as method
of completion (e.g. paper-based or electronic) and content
(ranging from general items tomore disease-speciﬁc symptoms).
PROMs are useful for research purposes, clinical monitoring and
more recent applications include service improvement and na-
tional benchmarking (e.g. the National PROMs programme in
England for elective procedures). In addition to this established
programme, several PROMs pilots are in progress in the UK,
looking at long-term conditions (LTCs) in primary care, de-
pression in secondary care, cardiac revascularization and skin
cancer.
Maintenance (11) Technological and information governance issues
• Ensure lack of familiarity with technology does not limit participation
• Ensure technology has the capacity for ﬂexibility over time
• Consider issues of data security and information governance
• Establish and address the legal and ethical constraints of the country/state
• Develop a coordinated IT infrastructure
• Consider availability of technology across different participating countries
• Maintain database so that patient information is up to date
• Obtain legal advice on the data sharing agreements that may be necessary
• Get the technology working before rolling it out-slow technology can be a barrier
(12) Useful high-impact output
• Maintain interest by maximizing published output in a range of formats
• Target different stakeholder group with outcomes of PROMs work
• Present patient-level data in a readily understandable format
• Highlight the direct beneﬁt to patients from participation
• Use ongoing nature of data to ensure frequent analysis and dissemination
• Data should aim to help improve patient care
• Make data as freely available as possible within the constraints of conﬁdentiality
(13) Maintaining trust/faith in the data
• Ensure methodological rigour to maintain trust
• Be aware of the sensitivity of centres to publication of data that reﬂects poorly on their performance
• Ensure objectives and evaluation are transparent and set by stakeholders and not any group for example with a vested interest
• Be aware that PROMs viewed more positively if presented as a care management tool
• Report characteristics of responders and non-responders ND
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Several challenges have been identiﬁed through such pilot
studies including poor response rates and concerns about
benchmarking and performance management. However bene-
ﬁts include the value of individual patient monitoring, plus the
potential for service improvement.
Selection of a PROM should be informed by a systematic re-
view of the literature reporting psychometric properties and
consideration of the practicalities of data collection. In 2009
the PROM group, University of Oxford, was commissioned
by the Department of Health in England to review PROMs
for chronic kidney disease and established renal failure [25]. Re-
commendations based on the strength of evidence included the
SF-36 [26], EQ-5D-5L [27] and KDQOL™-36 [28] measures.
When selecting a PROM, consideration needs to be given to
the purpose of measurement and practicalities of data collec-
tion. Complexity of scoring may outweigh the beneﬁts of preci-
sion whereas short versions of instruments with narrow focus
and simple indices may not provide breadth of information.
Data linkage and clinical information systems can support col-
lection and feedback of the data but may be complex to develop
and maintain.
Patient-reported experience measures—Dr Sabine van
der Veer, Amsterdam Medical Center, the Netherlands
Patient experience has long since been acknowledged as an
important dimension of quality of care [29]. Whereas patient
satisfaction is the perceived discrepancy between the expected
and experienced quality of care, the construct of patient experi-
ence attempts to exclude the former element from the equation
[30]. However, when translating these two constructs into ac-
tual measurement instruments, the distinction between them
often becomes less clear.
During the consensus meeting, eight instruments were dis-
cussed that were either available in English or on which an
English publication was available in PubMed [31–38]. Most in-
cluded items on a broad spectrum of care delivery aspects [31,
32, 35, 36, 38]; others focussed on capturing experiences with
speciﬁc aspects like education, or with treatment in general
[32, 33, 36]. The number of items varied widely between instru-
ments, ranging from eleven in the Renal Treatment Satisfaction
Questionnaire [33] to over 60 in the Scottish Renal Patient
Experience Survey [36]. Only two instruments were applicable
to any type of RRT [33, 37], while others were designed for one
[32, 34] or more dialysis modalities [31, 35, 36, 38].
Almost all instruments were developed with input from pa-
tients: for example, focus groups or interviews which identiﬁed
relevant aspects of care [31–33, 35, 38] or cognitive testing of a
preliminary version of the instrument [32, 33, 38]. In most
cases, developers evaluated the instruments’ internal consist-
ency [33–35, 38, 39]. Some also assessed construct validity by
exploring the correlation between patient experience as mea-
sured by the instrument and global assessments of satisfaction
[34, 38], clinical performance [31] or health-related quality of
life [34]. Outside a development context, wide scale use has only
been reported for the CHOICE and the CAHPS questionnaire
[40, 41].
Shared decision-making—Dr Hilary Bekker, University
of Leeds, UK
Measures used to assess shared decision making are predom-
inantly self-report questionnaires designed to evaluate a decision
support intervention’s effectiveness [12, 42–45] and/or screen for
decisional outcomes within usual care [46–51]. The substantial
number of measures available reﬂects the complexity of these in-
terventions in terms of their impact on different people within
the process of delivering care and components needed to en-
hance people’s active reasoning and engagement with others
[52] (Figure 2).
F IGURE 2 : A framework representing informed, evidence-based and shared decisions with people and their healthcare roles.
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Decision support intervention types include:
• Patient Decision Aids [12, 45] enabling people to make
informed decisions (point 1, Figure 2) between options by
consideration of accurate information about all options
and their consequences without bias, evaluation of this
information with their values and making a decision on
trade-offs between evaluations [12, 53, 54]. There are several
patient-reported informed decision outcome measures [37,
38, 46–50, 55–59]. Alternatively, proxy outcomes may
be used to assess an aid’s impact by capturing people’s
knowledge, risk perception, values, involvement, activation,
usefulness intervention, value-choice consistency and/or
decision quality [12, 45, 60–62].
• Professional Decision Support [63] enabling professionals to
make evidence-based choices (point 2, Figure 2) by using the
best evidence available, in consultationwith the patient, to de-
cide upon the option which best suits that patient [64].
• Shared Decision-Making Support [65–68] within patient-
professional consultations enabling the process of choosing
healthcare collaboratively (point 3, Figure 2) by exchanging
information, preferences and values about treatments, expli-
cit reasoning about choices and agreeing a choice and im-
plementation plan. Some measures assess patient-reported
shared decision making outcomes [48, 69, 70]. Proxy out-
comes assess an aid’s impact on the professional (e.g. pro-
vided option information, elicited values, awareness of
patient experience, etc.), [71–73] the patient (e.g. asked
questions, provided values, awareness of professional view-
point, etc.) [61, 62, 74–76] and/or the concordance between
patient-professional factors (e.g. SDM-Q-9; decisional con-
ﬂict) [77–79].
When informed [56, 57, 59] and shared [60] decision out-
comes are used in renal services, ﬁndings suggest that they
are useful service-quality indicators [49, 50, 77, 80]. However,
they may respond differently from application in other con-
texts, as they are not designed for decisions taking place across
multiple consultations, health professionals and services, with
delayed implementation and chronically ill, elderly and/or
often frail patients [80].
REACHING A CONSENSUS
The second part of the meeting addressed the objective of har-
monizing the routine collection of patient-reported data by
renal registries in Europe by agreeing on preferred instruments
and discussing some of the practicalities of this process. Atten-
dees were divided into four groups and asked to discuss which
of the PROM/PREM instruments on a list should be employed,
how often they should be administered and in what format. Due
to time constraints and as they had not been included in the ori-
ginal application for funding it was decided to exclude the
measurement of Shared Decision Making from the consensus
discussions. Groups were chaired by four of the attendees,
who later reported back to the whole meeting. Discussions
were also audio-recorded. Participants were also asked to vote
on which PROMs/PREMs they thought would be most appro-
priate based on the evidence outlined throughout the course of
the meeting.
(i) PROM instruments. The overwhelming consensus was
that any PROMs measurement programme should aim
to support improvements in the quality of care for pa-
tients. In terms of the measures adopted, there was agree-
ment that the programme should aim to include both
generic and disease-speciﬁc measures if possible,
whilst minimizing the overall length of questionnaires
administered. Of all the instruments discussed, the
KDQOL™-36 seemed to be preferred by delegates as it
offers both generic and disease-speciﬁc outcomes. Of
the generic instruments, the SF-12 [81] was themost pre-
ferred. The importance of capturing patient symptoms
was recognized, especially if a generic health-related
quality of life instrument was being used, but no pre-
ferred symptom burden instrument was agreed on.
There was not complete agreement on whether a
preference-based measure should be included, but con-
sensus suggested that it would be useful to have a meas-
ure that would allow health economic evaluations
provided that the length was not prohibitive. The
EQ-5D-5L was the preferred instrument for this purpose
but it was recognized that SF-6D [82], which could also
provide the utility data necessary for calculating quality
adjusted life years in health economic evaluations,
could be derived from longer SF instruments (Table 2)
[82, 83].
(ii) PREM instruments. Delegates were much less familiar
with the various PREM instruments available. Therefore,
although the strengths and weaknesses of the various in-
struments had been presented to them earlier in the
meeting, there was a broad consensus that more work
was needed to recommend speciﬁc PREMs for broader
use.
(iii) Patient groups to be covered. There was a clear consensus
that the aim should be to include all patients on RRT in
any PROMs/PREMs programme, and that data should
be collected on at least an annual basis. The possibility
Table 2. Summary of recommendations from consensus discussions for
routine renal registry PROM collection
Consensus
Which instruments
Generic SF-12
Preference-based EQ-5D-5L
Kidney speciﬁc KDQOL™-36
Practical issues
Who? All patients on RRT
When? At least annually
Preferably not during dialysis
How? Unassisted self-report
No clear preference for paper/web
Other issues Consider ethics/consent/data protection
Conduct initial pilot study
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of extending coverage to pre-dialysis patients in the fu-
ture, when these patients are captured by registries, was
discussed. The importance of making patients aware of
how the data were being used was emphasized if high re-
sponse rates were to be achieved from a broad range of
patients. Several issues relating to the timing of data col-
lection were discussed, and the general view was that al-
though it may be useful to collect data at speciﬁc time
points (e.g. in relation to commencement of RRT), this
may not be feasible. As regards timings, the patient rep-
resentative suggested that patients may not wish to com-
plete PROMs/PREMs questionnaires whilst attending for
dialysis and PROM experts raised concerns that re-
sponses given while on dialysis may be sensitive to the
current dialysis experience rather than ‘usual’ health-
related quality of life. No clear preference for paper or
web-based reporting emerged, but the group felt that
data should be collected via unassisted self-reporting.
Other issues that featured prominently in discussions
were the need to consider the legal, data protection and
consent constraints of participating countries, and the
possibility of a pilot study to assess feasibility.
There are limitations to this report. There is a scarcity of ro-
bust data on measuring and reporting PROMs and PREMs in
kidney patients. Further, as mentioned above, the instruments
available were generally developed for measurement at the in-
dividual patient level, rather than the centre or national level. In
someways these limitations reﬂect the attempt to reach consen-
sus across European renal registries before instruments and
processes become established.
SUMMARY
From the survey of European renal registry representatives and
discussions with those attending the meeting there seems to be
a widespread acceptance of the need to extend renal registry
data collection to capture patient-reported outcomes and ex-
perience. It is recognized that this represents a considerable
challenge for renal registries and services if all the potential ben-
eﬁts from the information gathered—such as focussing consul-
tations on what matters to patients, having real-life information
on quality of life for decision-making, incorporating patient
measures into the quality assurance of renal units, research
and improving services—are to be realized. Establishing a dia-
logue between registries around PROMs/PREMs and agreeing
on some preferred measures at this stage will hopefully enable
the sharing of expertize and experience and stimulate the col-
lection, and facilitate the collection and comparison of patients’
outcomes and experiences across Europe in the future.
SUPPLEMENTARY DATA
Supplementary data are available online at http://ndt.oxford
journals.org.
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